We have located links that may give you full text access.
Microvascular complications are associated with coronary collateralization in type 2 diabetes and chronic occlusion.
Journal of Clinical Endocrinology and Metabolism 2023 July 8
CONTEXT: Coronary collateral (CC) vessel development appears to be protective with regard to adverse cardiovascular events and survival in patients with coronary chronic total occlusion (CTO). The influence of type 2 diabetes mellitus (T2DM) on CC growth has been controversial. In particular, the role of diabetic microvascular complications (DMC) in determining coronary collateralization has not been elucidated.
OBJECTIVE: To investigate whether patients with DMC presented differences in CC vessels presence and grading as compared to those without DMC.
METHODS: We conducted a single-center observational study, including consecutive T2DM patients without previous cardiovascular history, undergoing a clinically indicated coronary angiography for chronic coronary syndrome (CCS) and angiographic evidence of at least one CTO. Patients were subdivided into two study groups according to the presence/absence of at least one of DMC (either neuropathy, nephropathy of retinopathy). The presence and the grading of angiographically visible CC development from the patent vessels to the occluded artery were assessed using the classification developed by Rentrop et al.
RESULTS: We enrolled in total 157 patients (mean age 68.6±9.8 years; 120 [76.4%] men). Patients with DMC (75 [47.8%]) had a higher prevalence of CC (69 [92.0%] vs. 62 [75.6%], p = 0.006) and high-grade CC (55 (73.3%) vs. 39 (47.6%), p = 0.001] compared to those without and a positive association between the number of DMC in each patient and the prevalence of high-grade CC was found.
CONCLUSIONS: Among T2DM patients with coronary CTO, the presence of DMC was associated with a high CC development.
OBJECTIVE: To investigate whether patients with DMC presented differences in CC vessels presence and grading as compared to those without DMC.
METHODS: We conducted a single-center observational study, including consecutive T2DM patients without previous cardiovascular history, undergoing a clinically indicated coronary angiography for chronic coronary syndrome (CCS) and angiographic evidence of at least one CTO. Patients were subdivided into two study groups according to the presence/absence of at least one of DMC (either neuropathy, nephropathy of retinopathy). The presence and the grading of angiographically visible CC development from the patent vessels to the occluded artery were assessed using the classification developed by Rentrop et al.
RESULTS: We enrolled in total 157 patients (mean age 68.6±9.8 years; 120 [76.4%] men). Patients with DMC (75 [47.8%]) had a higher prevalence of CC (69 [92.0%] vs. 62 [75.6%], p = 0.006) and high-grade CC (55 (73.3%) vs. 39 (47.6%), p = 0.001] compared to those without and a positive association between the number of DMC in each patient and the prevalence of high-grade CC was found.
CONCLUSIONS: Among T2DM patients with coronary CTO, the presence of DMC was associated with a high CC development.
Full text links
Related Resources
Trending Papers
Obesity pharmacotherapy in older adults: a narrative review of evidence.International Journal of Obesity 2024 May 7
SGLT2 Inhibitors in Kidney Diseases-A Narrative Review.International Journal of Molecular Sciences 2024 May 2
Use of Intravenous Albumin: A Guideline from the International Collaboration for Transfusion Medicine Guidelines.Chest 2024 March 5
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app